FDA Brief

Warning letters Food

FDA warning letter to

CNC Noodle Corporation

High riskIssued Oct 15Posted Nov 17Human Foods Program

FDA warned CNC Noodle Corporation that its Hayward, California noodle plant had insanitary conditions, no pathogen or allergen controls, and mislabeled products.

What happened

FDA inspected the noodle facility from January 13 to January 28, 2026 and found that food-contact surfaces were not sanitized, equipment was dirty, and condensate dripped onto exposed noodles. FDA also found the company's hazard analysis did not treat Bacillus cereus, Clostridium botulinum, or undeclared wheat as hazards needing controls, and that cooling temperatures for sealed Pan Fried Noodles were not controlled. The company recalled Steam Noodles and Chao Mian Noodles on March 2, 2026 for undeclared wheat, and FDA said the responses did not include an updated hazard analysis, allergen procedures, or monitoring records.

What FDA found

  1. The company did not treat growth and toxin formation by Bacillus cereus and Clostridium botulinum as a hazard needing a preventive control for its sealed Pan Fried Noodles, and it had no time or temperature control during cooling.

    21 CFR 117.130(a)(1) and 21 CFR 117.135(c)(1)
  2. The company's hazard analysis did not treat undeclared wheat as a hazard needing a preventive control, and several products shipped without wheat declared on the label.

    21 CFR 117.135(c)(2)(i) and (ii)
  3. The company did not use sanitizer on food-contact surfaces, and product residue remained on the Pan Fried noodle line after cleaning.

    21 CFR 117.35(a)
  4. Employees placed a hose nozzle on a wet floor and then handled noodles without changing gloves or washing hands, and there were no handwashing sinks in the processing areas.

    21 CFR 117.35(a)
  5. Fan blades with visible dirt blew directly onto cooling noodles, and condensate dripped onto the steamed noodle line.

    21 CFR 117.80(c)(2)
  6. Labels failed to declare wheat as a major food allergen and listed ingredients the company does not use, such as eggs and soybean oil.

    Section 403(w) and section 403(a)(1) of the Federal Food, Drug, and Cosmetic Act

What FDA wants

FDA tells the company to reply in writing within 15 working days describing each step taken to fix the violations and prevent recurrence, with supporting documentation. If corrective actions cannot be finished in that time, the company must explain the delay and give a completion date.

Who should pay attention

  • retailers and distributors that sell fresh noodle or wonton products
  • food brands that buy noodles or wrappers from contract manufacturers
  • quality teams responsible for allergen labeling and food safety plans

This is a summary. Read the original letter on fda.gov.

CNC Noodle Corporation's FDA history

Recalls in the last 12 months

Mar 18 Class II CNC Noodle Corporation
Food
Secondary Packaging: STEAM NOODLES INGREDIENTS: ENRICHED FLOUR, WATER, STARCH, SALT, POTASSIUM, CARBONATE AND BENZOATE OF SODA ADDED AS PRESERVATIVEM F.D. & C. YELLOW COLOR #5 & #6 (TARTRAZINE) ARTIFICIAL COLORS) Primar…
Undeclared wheat.
Mar 18 Class II CNC Noodle Corporation
Food
Secondary Packaging: ZHONG HUA CHAO MIAN NOODLE INGREDIENTS: ENRICHED FLOUR, WATER, STARCH, SALT, POTASSIUM, CARBONATE AND BENZOATE OF SODA ADDED AS PRESERVATIVE F.D. & C. YELLOW COLOR #5 & #5 (TARTRAZINE) ARTIFICIAL COL…
Undeclared wheat and Yellow #6.

Full company page

Similar letters to other companies

  1. USV Private Limited

    FDA warned USV Private Limited that its sterile injectable manufacturing in Daman, India, had aseptic-processing, facility-design and visible-particulate violations.

    High risk
  2. Next Medical Products Company, LLC

    FDA warns Next Medical Products that its ultrasound gels were contaminated and made without required quality controls or clearance.

    High risk
  3. Northland Nuclear Medicine, LLC

    FDA warned Northland Nuclear Medicine in Bismarck, ND, that its PET drugs are adulterated because it failed to investigate microbial contamination and low yields.

    High risk
  4. Rohto Pharmaceutical Co., Ltd.

    FDA cites Rohto Vietnam eye-drop plant for falsified sterility records, poor aseptic practices, and unapproved Cooling Eye Drops.

    High risk